1-4 of 4
Rahima Jamal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A First-in-Human, Open-Label, Phase I Dose Escalation Trial of Daily Oral Nmt Inhibitor Zelenirstat in Patients with Relapsed/Refractory B-Cell Lymphomas and Advanced Solid Tumors

Randeep Sangha, Rahima Jamal, Jennifer Spratlin, John Kuruvilla, Laurie H. Sehn, Michael Weickert, Luc Berthiaume, John Robert Mackey
Journal: Blood
Blood (2023) 142 (Supplement 1): 6241.
https://doi.org/10.1182/blood-2023-190058
Published: 2023
Journal Articles

A First in Class, Open-Label, First-in-Human, Phase I Trial of Daily Oral Pclx-001

Randeep Sangha, Laurie H. Sehn, Rahima Jamal, Jennifer Spratlin, John Kuruvilla, Michael J. Weickert, Luc G. Berthiaume, John R. Mackey
Journal: Blood
Blood (2022) 140 (Supplement 1): 12057–12058.
https://doi.org/10.1182/blood-2022-168140
Published: 2022
Journal Articles

A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,

Sarit Assouline, MD, Biljana Kraljacic-Culjkovic, PhD, Eftihia Cocolakis, PhD, Abdellatif Amri, Julie Bergeron, MD, Rahima Jamal, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB Borden, PhD
Journal: Blood
Blood (2011) 118 (21): 3606.
https://doi.org/10.1182/blood.V118.21.3606.3606
Published: 2011
Journal Articles

Retrospective Study of Trough Imatinib Plasma Levels Conducted as Part of the Follow-up of Patients with Chronic Myeloid Leukemia in a Canadian Cohort

Rahima Jamal, MD, Danielle Desmarais, Ph.D, John Chapdelaine, B.Sc., Yvan Côté, Ph.D., Lambert Busque, MD
Journal: Blood
Blood (2008) 112 (11): 4258.
https://doi.org/10.1182/blood.V112.11.4258.4258
Published: 2008